703
Views
0
CrossRef citations to date
0
Altmetric
Original Research Article

Opioid prescriptions among Sami and non-Sami with chronic pain: The SAMINOR 2 Questionnaire Survey and the Norwegian Prescription Database

, , , &
Article: 2241202 | Received 01 Dec 2022, Accepted 21 Jul 2023, Published online: 28 Jul 2023

References

  • Pedersen P, Høgmo A, Solbakk JT. Sápmi slår tilbake : samiske revitaliserings- og moderniseringsprosser i siste generasjon. Kárášjohka: ČálliidLágádus; 2012.
  • Minde H. Fornorskinga av samene : hvorfor, hvordan og hvilke følger? Kautokeino: Kompetansesenteret for urfolks rettigheter 2005 Vol. nr 3/2005.
  • Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287. doi: 10.1016/j.ejpain.2005.06.009
  • Leadley RM, Armstrong N, Lee YC, et al. Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain. J Pain Palliat Care Pharmacother. 2012;26(4):310–11. doi: 10.3109/15360288.2012.736933
  • Knudsen AKS, Tollånes MC, Haaland ØA, Kinge JM, Skirbekk VF, Vollset SE. Sykdomsbyrde i Norge 2015. In: Resultater fra global burden of diseases, injuries, and risk factors study 2015 (GBD 2015). Oslo: Folkehelseinstituttet, Senter for sykdomsbyrde, Område for psykisk og fysisk helse; 2017.
  • Landmark T, Romundstad P, Borchgrevink PC, et al. Associations between recreational exercise and chronic pain in the general population: Evidence from the HUNT 3 study. Pain. 2011;152(10):2241–2247. doi: 10.1016/j.pain.2011.04.029
  • Samuelsen P-J, Svendsen K, Wilsgaard T, et al. Persistent analgesic use and the association with chronic pain and other risk factors in the population—a longitudinal study from the Tromsø Study and the Norwegian Prescription Database. Eur J Clin Pharmacol. 2016;72(8):977–985. doi: 10.1007/s00228-016-2056-7
  • Jimenez N, Garroutte E, Kundu A, et al. A Review of the Experience, Epidemiology, and Management of Pain among American Indian, Alaska Native, and Aboriginal Canadian Peoples. J Pain. 2011;12(5):511–522.
  • McDougall CMD, Hurd KMD, Barnabe CMDM. Systematic review of rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand. Semin Arthritis Rheum. 2017;46(5):675–686. doi: 10.1016/j.semarthrit.2016.10.010
  • Loder S, Sheikh HU, Loder E. The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from national survey studies. Headache. 2015;55(2):214–228. doi: 10.1111/head.12506
  • Eliassen B-M, Graff-Iversen S, Melhus M, et al. Ethnic difference in the prevalence of angina pectoris in sami and non-sami populations: the SAMINOR study. Int J Circumpolar Health. 2014;73(1):21310. doi: 10.3402/ijch.v73.21310
  • Hansen KL, Brustad M, Johnsen K. Prevalence of self-reported stomach symptoms after consuming milk among indigenous sami and non-sami in northern- and mid-Norway - the SAMINOR study. Int J Circumpolar Health. 2015;74(1):25762. doi: 10.3402/ijch.v74.25762
  • Eriksen A, Schei B, Hansen K, et al. Childhood violence and adult chronic pain among indigenous Sami and non-Sami populations in Norway: a SAMINOR 2 questionnaire study. Int J Circumpolar Health. 2016;75(1):32798. doi: 10.3402/ijch.v75.32798
  • Eckhoff C, Kvernmo S. Musculoskeletal pain in Arctic indigenous and non-indigenous adolescents, prevalence and associations with psychosocial factors: a population-based study. BMC Public Health. 2014;14(1):617. doi: 10.1186/1471-2458-14-617
  • Damsgård E, Thrane G, Fleten N, et al. Persistent pain associated with socioeconomic and personal factors in a sami and non-sami population in Norway: an analysis of SAMINOR 2 survey data. Int J Circumpolar Health. 2020;79(1):1787022. doi: 10.1080/22423982.2020.1787022
  • Busse JW, Wang L, Kamaleldin M, et al. Opioids For chronic noncancer pain: a systematic review and meta-analysis. JAMA. 2018;320(23):2448–2460. doi: 10.1001/jama.2018.18472
  • Pergolizzi J, Böger RH, Budd K, et al. Opioids and The management of chronic severe pain in the elderly: consensus statement of an international expert panel with focus on the six clinically most often used world health organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008;8(4):287–313. doi: 10.1111/j.1533-2500.2008.00204.x
  • Shmagel A, Ngo L, Ensrud K, et al. Prescription Medication Use Among Community-Based U.S. Adults with Chronic Low Back Pain: A Cross-Sectional Population Based Study. J Pain. 2018;19(10):1104–1112. doi: 10.1016/j.jpain.2018.04.004
  • Ekholm O, Kurita GP, Højsted J, et al. Chronic pain, opioid prescriptions, and mortality in Denmark: A population-based cohort study. Pain. 2014;155(12):2486–2490. doi: 10.1016/j.pain.2014.07.006
  • Humphreys K, Shover CL, Andrews CM, et al. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–lancet commission. Lancet. 2022;399(10324):555–604. doi: 10.1016/S0140-6736(21)02252-2
  • Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182–186. doi: 10.2105/AJPH.2017.304187
  • Lee B, Zhao W, Yang K-C, et al. Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018. JAMA Netw Open. 2021;4(2):e2036687. doi: 10.1001/jamanetworkopen.2020.36687
  • Fischer B. The continuous opioid death crisis in Canada: changing characteristics and implications for path options forward. Lancet Reg Health Am. 2023;19:100437. doi: 10.1016/j.lana.2023.100437
  • Bosetti C, Santucci C, Radrezza S, et al. Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990–2016. Eur J Pain. 2019;23(4):697–707. doi: 10.1002/ejp.1337
  • Daveluy A, Micallef J, Sanchez‐Pena P, et al. Ten‐year trend of opioid and nonopioid analgesic use in the French adult population. Br J Clin Pharmacol. 2021;87(2):555–564. doi: 10.1111/bcp.14415
  • Alford DP. Opioid prescribing for chronic pain — achieving the right balance through education. N Engl J Med. 2016;374(4):301–303. doi: 10.1056/NEJMp1512932
  • NIPH. Norwegian Institute of Public Health [internet]. n.d. [Available from: https://www.fhi.no/en/
  • Hamina A, Odsbu I, Borchgrevink PC, et al. CohorT description: preventing an opioid epidemic in Norway - focusing on treatment of chronic pain (POINT) - a national registry-based study. Clin Epidemiol. 2022;14:1477–1486. doi: 10.2147/CLEP.S382136
  • Muller AE, Clausen T, Sjøgren P, et al. Prescribed opioid analgesic use developments in three Nordic countries, 2006–2017. Scand J Pain. 2019;19(2):345–353. doi: 10.1515/sjpain-2018-0307
  • Pletcher MJ, Kertesz SG, Kohn MA, et al. Trends in opioid prescribing by race/ethnicity for patients seeking care in us emergency departments. JAMA. 2008;299(1):70–78. doi: 10.1001/jama.2007.64
  • Chen I, Kurz J, Pasanen M, et al. Racial differences in opioid use for chronic nonmalignant pain. J Gen Intern Med. 2005;20(7):593–598. doi: 10.1007/s11606-005-0105-5
  • Heins JK, Heins A, Grammas M, et al. Disparities in analgesia and opioid prescribing practices for patients with musculoskeletal pain in the emergency department. J Emerg Nurs. 2006;32(3):219–224. doi: 10.1016/j.jen.2006.01.010
  • Shavers VL, Bakos A, Race SV. Ethnicity, and pain among the U.S. Adult Population. J Health Care Poor Underserved. 2010;21(1):177–220. doi: 10.1353/hpu.0.0255
  • Harrison JM, Lagisetty P, Sites BD, et al. Trends in prescription pain medication use by race/ethnicity among us adults with noncancer pain, 2000-2015. Am J Public Health. 2018;108(6):788–790. doi: 10.2105/AJPH.2018.304349
  • Tamayo‐Sarver JH, Dawson NV, Hinze SW, et al. The effect of race/ethnicity and desirable social characteristics on physicians’ decisions to prescribe opioid analgesics. Acad Emerg Med. 2003;10(11):1239–1248. doi: 10.1197/S1069-6563(03)00494-9
  • Staton LJ, Panda M, Rosenberg E, et al. When race matters: Disagreement in pain perception between patients and their physicians in primary care. J Natl Med Assoc. 2007;99(5):532–538.
  • Rahim‐Williams B, Riley JL, Williams AKK, et al. A quantitative review of ethnic group differences in experimental pain response: do biology, psychology, and culture matter? Malden, USA2012. Pain Med. 2012;13(4):522–540. doi: 10.1111/j.1526-4637.2012.01336.x
  • Ibrahim SA, Burant CJ, Mercer MB, et al. Older patients’ perceptions of quality of chronic knee or hip pain: differences by ethnicity and relationship to clinical variables. J Gerontol A Biol Sci Med Sci. 2003;58(5):M472–M7. doi: 10.1093/gerona/58.5.M472
  • Javo C, Ronning JA, Heyerdahl S. Child-rearing in an indigenous Sami population in Norway: a cross-cultural comparison of parental attitudes and expectations. Scand J Psychol. 2004;45(1):67–78. doi: 10.1111/j.1467-9450.2004.00380.x
  • NIPH. WHO Collaborating Centre for Drug Statistics Methodology. In: ATC classification index with DDDs. Norway; n.d. https://www.fhi.no/en/he/drug/who-collaborating-centre-for-drug-statistics-methodology/
  • Helsedirektoratet. Ny nasjonal veileder for vanedannende legemidler Tilgjengelig fra https://www.helsedirektoratet.no/nyheter/ny-nasjonal-veileder-for-vanedannende-legemidler2021.
  • Clarke H, Bao J, Weinrib A, et al. Canada’s hidden opioid crisis: the health care system’s inability to manage high-dose opioid patients: Fallout from the 2017 Canadian opioid guidelines. Can Fam Physician. 2019;65(9):612–614.
  • Clausen T. What lessons from Norway’s experience could be applied in the United States in response to the addiction and overdose crisis? Addiction. 2022;117(5):1192–1194. doi: 10.1111/add.15845
  • Keto J, Heiskanen T, Hamunen K, et al. Opioid trends in Finland: a register-based nationwide follow-up study. Sci Rep. 2022;12(1):7261. doi: 10.1038/s41598-022-10788-7
  • Fugelstad A. What lessons from Sweden’s experience could be applied in the United States in response to the addiction and overdose crisis? Addiction. 2022;117(5):1189–1191. doi: 10.1111/add.15847
  • GC. Government of Canada [internet]. 2023 [Available from: https://www.canada.ca/en/health-canada/services/opioids/federal-actions/overview.html#a2.
  • Fredheim OMS, Mahic M, Skurtveit S, et al. Chronic pain and use of opioids: A population-based pharmacoepidemiological study from the Norwegian prescription database and the nord-trøndelag health study. Pain. 2014;155(7):1213–1221. doi: 10.1016/j.pain.2014.03.009
  • Anderson I, Robson B, Connolly M, et al. Indigenous and tribal peoples’ health (the lancet–lowitja institute global collaboration): a population study. Lancet. 2016;388(10040):131–157. doi: 10.1016/S0140-6736(16)00345-7
  • Norum J, Nieder C. Socioeconomic characteristics and health outcomes in sami speaking municipalities and a control group in northern norway. Int J Circumpolar Health. 2012;71(1):19127. doi: 10.3402/ijch.v71i0.19127
  • Brustad M, Hansen KL, Broderstad AR, et al. A population-based study on health and living conditions in areas with mixed sami and Norwegian settlements – the SAMINOR 2 questionnaire study. Int J Circumpolar Health. 2014;73(1):23147. doi: 10.3402/ijch.v73.23147
  • ILO. Indigenous and tribal peoples convention, (No.169). 1989.
  • Edvardsen HME, Clausen T. Opioid related deaths in Norway in 2000–2019. Drug Alcohol Depend. 2022;232:109281. doi: 10.1016/j.drugalcdep.2022.109281
  • Skurtveit S, Odsbu I, Gjersing L, et al. Individuals dying of overdoses related to pharmaceutical opioids differ from individuals dying of overdoses related to other substances: a population-based register study. Eur Addict Res. 2022;28(6):419–424. doi: 10.1159/000526145